Circady Wins 2019 MedTech Breakthrough Award for “Best Sleep Monitoring Solution”

Circady, an innovative insomnia treatment created from our digital health research program SleepWell, won a 2019 MedTech Breakthrough Award for "Best Sleep Monitoring Solution."

Insomnia is a common symptom of PTSD that can have debilitating effects.

Approximately 70-91% of PTSD patients have difficulty falling or staying asleep.

Circady, an innovative insomnia treatment created from our digital health research program SleepWell, won a 2019 MedTech Breakthrough Award for “Best Sleep Monitoring Solution.”

Insomnia is a common symptom of PTSD and TBI that can have a debilitating impact on patients, and early intervention is critical to preempt disease progression associated with physical or emotional trauma,” said Magali Haas, MD, PhD, CEO and President, Cohen Veterans Bioscience. We think it is critical to support this technology in tracking sleep, which enables healthcare providers to define individual health trajectories and customize treatment to improve the everyday lives of those suffering from sleep disorders.”

Read the press release on PRWeb and learn more.

Share this article:

More from CVB

https://www.cohenveteransbioscience.org/wp-content/uploads/2023/02/cvb-pr-2-21-23-data-visualization-featuredimage.jpg

Untapped potential of machine learning techniques for Parkinson’s Disease research and healthcare

https://www.cohenveteransbioscience.org/wp-content/uploads/2022/12/btb-action-summit-mh-cropped.jpg

Cohen Veterans Bioscience Announces ‘Call for National TBI Action Coalition’

About Cohen Veterans Bioscience (CVB)

Cohen Veterans Bioscience is a non-profit 501(c)(3) biomedical research and technology organization dedicated to advancing brain health by fast-tracking precision diagnostics and tailored therapeutics.

For Media Inquiries

Please feel free to email us at media@cohenbio.org